Clenbuterol treatment is safe and associated with slowed disease progression in a small open-label trial in patients with amyotrophic lateral sclerosis
,
Good candidates Researchers studying anti-aging interventions Those investigating wound healing acceleration Researchers exploring hair and skin improvements Those combining with other peptides in tissue repair stacks Researchers with experience handling injectable compounds Poor candidates Individuals with Wilson's disease or copper metabolism disorders Those with active cancer or history of hormone-sensitive cancers (until more research exists) Pregnant or breastfeeding individuals Those taking anticoagulant medications (potential interaction concerns) Individuals with known copper allergies or sensitivities Anyone uncomfortable with self-injection or unable to maintain sterile technique When uncertain, consult a healthcare provider familiar with peptide research before beginning any protocol
Kovcs R, Gerevich Z, Friedman A, Othal J, Prager O, Gabriel S, Berndt N (2018) Bioenergetic mechanisms of seizure control
However, the exact connection between the peptide and this pathway is still not fully understood
postulated to be responsible for the high incidence of severe necrotic skin infections and ulcerations Severe skin infections often require hospitalization with treatment including i.v
